Dr. Reve Purisima Shields, MD

  • Brockton, MA
  • Hematologist and oncologist
NPI1871719187PAC ID1759551658
Medicare services, 2024
1,177
Medicare patients, 2024
457
Part D claims, 2024
1,163
Publications
1
MIPS score, 2024
89
Practice address
680 Center Street, Brockton, MA 02302
Practice phone
Call (508) 941-7000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Signature Healthcare Brockton Hospital

Hospital · Brockton, Massachusetts

See all 6 affiliations

Find Dr. Shields' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Reve Purisima Shields is a hematologist and oncologist in Brockton, Massachusetts

Dr. Shields practices at Signature Healthcare Brockton Hospital in Brockton, Massachusetts, part of Signature Healthcare.

Dr. Shields' NPI, 1871719187, was assigned on April 17, 2007. Dr. Shields graduated from State Un of NY, Stony Brook School of Dental Med in 2005. Dr. Shields holds Massachusetts license 247435.

NPI and contact details
Medicare PAC ID
1759551658
NPI enumeration date
April 17, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(508) 941-7000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Reve Purisima Shields practices at Signature Healthcare Brockton Hospital in Brockton, Massachusetts

Dr. Shields' primary practice is Signature Healthcare Brockton Hospital, at 680 Center Street, Brockton, MA 02302 in Plymouth County. The practice phone is (508) 941-7000.

Source: Dmand AI Affiliation Data

Dr. Reve Purisima Shields is affiliated with 5 sites of care and 1 medical group

Dr. Shields' primary practice is Signature Healthcare Brockton Hospital in Brockton, Massachusetts, part of Signature Healthcare. Dr. Shields is also affiliated with Boston Medical Center - South. The medical group on file is Signature Medical Group. Dmand AI also links Dr. Shields to 1 more hospital, 1 imaging center and 1 urgent care center, each named with a free account.

See all 6 affiliations for Dr. Shields

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Reve Purisima Shields' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shields practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Signature Healthcare Brockton HospitalAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Shields practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Signature Healthcare and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Reve Purisima Shields is one of 429 hematologists and oncologists in Massachusetts

Hematology and oncology is Dr. Shields' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shields is licensed in Massachusetts.

Specialties and state licenses

  • Hematology and oncology, MassachusettsPrimaryLicense 247435 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Shields

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Reve Purisima Shields billed Medicare for 1,177 services in 2024

CMS data shows 1,177 Medicare services from Dr. Shields across 6 procedure codes in 2024, for 457 Medicare patients. Medicare paid $101,244 for them.

Medicare services, 20241,177
Medicare patients457
Paid by Medicare$101,244
Procedure codes6

Dr. Shields' Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 8862024: 1,13228%
Surgery
2023: 862024: 4548%

Where Dr. Shields' Medicare services took place, 2024

  • In an office454%
  • In a facility1,13296%

Dr. Shields compared with the Massachusetts median for hematologists and oncologists, 2024

  • Dr. Shields
  • Massachusetts median
Medicare services
1,177vs 4952.4 times
Medicare patients
457vs 2002.3 times
Part D claims
894vs 1515.9 times

Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Shields' most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Shields

Need commercial claims for Dr. Shields?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Shields and other hematologists and oncologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Reve Purisima Shields treated 457 Medicare patients in 2024, average age 73

CMS counts 457 Medicare patients who saw Dr. Shields in 2024. The largest group is 65 to 74, with 185 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shields' median patient age at 63, with 76% women.

Medicare patients, 2024457
Average age73
Average risk score1.72
Also on Medicaid34%

Dr. Shields' Medicare patients by age, 2024

Dr. Shields' Medicare patients by sex, 2024

  • Women31669%
  • Men14131%

Chronic conditions among Dr. Shields' Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer48%
  4. Arthritis42%
  5. Anxiety35%
  6. Diabetes35%
  7. Mood disorders30%
  8. Chronic kidney disease29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Shields' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 63

Patient panel by sex, all payers

  • Women76%
  • Men23%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Reve Purisima Shields wrote 1,163 Medicare Part D claims in 2024

In 2024, Dr. Shields wrote 1,163 Medicare Part D claims for 250 patients. 79% of them were for generic drugs. CMS names the drug for 894 of them, across 23 drugs with 11 or more claims each, at $1,583,813 in total drug cost. In 2023, CMS named 594 claims across 18 drugs.

Part D claims, 20241,163
Drugs named by CMS23
Total drug cost$1.6M
Part D patients250

Dr. Shields' Part D claims by kind of drug, 2024

  • Generic914 claims79%
  • Brand-name249 claims21%

Dr. Shields' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Shields' Part D claims, 2024

  • Opioids5%60 of 1,163 claims
  • Antibiotics4%44 of 1,163 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5942024: 89451%

Drugs named by CMS: 23 in 2024, 18 in 2023.

See all prescribing by Dr. Shields

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Reve Purisima Shields scored 89 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shields for performance year 2024, reported as part of a group. Dr. Shields accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shields as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Shields' MIPS scores, performance year 2024

  • 89of 100Final score
  • 70.1of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Shields by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Reve Purisima Shields has 1 publication on record

Dmand AI links 1 paper to Dr. Shields in 2012. Dr. Shields' most frequent co-authors are Jorge J. Castillo, MD and Anthony Emmanuel Mega, MD.

Papers1

Dr. Shields' most frequent co-authors

Recent publications by Dr. Shields

See all 1 publications and co-authors

See who Dr. Shields researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Shields works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Reve Purisima Shields received $2,179 in industry payments from 2017 to 2025

CMS Open Payments shows 86 general payments to Dr. Shields from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Celgene Corporation paid the most, $241.

General payments to Dr. Shields by program year, 2017 to 2025

General payments to Dr. Shields by kind, 2017 to 2025

$2.2Kin total
  • Food and beverage$1,98891%
  • Education$1919%

Companies that paid Dr. Shields the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Shields

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Reve Purisima Shields graduated from State Un of NY, Stony Brook School of Dental Med

Dr. Shields graduated from State Un of NY, Stony Brook School of Dental Med in 2005.

  1. Medical schoolState Un of NY, Stony Brook School of Dental Med

Source: Dmand AI Professional Profile Data

Sources for Dr. Reve Purisima Shields's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Reve Purisima Shields

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Reve Purisima Shields' NPI number?

Dr. Reve Purisima Shields' NPI number is 1871719187. It was assigned on April 17, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Reve Purisima Shields?

Dr. Reve Purisima Shields is a hematologist and oncologist in Brockton, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Reve Purisima Shields practice?

Dr. Shields practices at 680 Center Street, Brockton, MA 02302. Dr. Shields' primary practice is Signature Healthcare Brockton Hospital in Brockton, Massachusetts, part of Signature Healthcare. Dmand AI also links Dr. Shields to 1 hospital, 1 imaging center and 1 urgent care center.

What is Dr. Reve Purisima Shields' office phone number?

The practice phone on file for Dr. Shields is (508) 941-7000.

What is Dr. Reve Purisima Shields' medical license number?

Dr. Shields holds Massachusetts license 247435.

Which hospitals is Dr. Reve Purisima Shields affiliated with?

Dr. Shields practices at Signature Healthcare Brockton Hospital in Brockton, Massachusetts. Dr. Shields is also affiliated with Boston Medical Center - South. Dmand AI links Dr. Shields to 1 more hospital.

What medical group is Dr. Reve Purisima Shields part of?

Dr. Shields is linked to Signature Medical Group.

Does Dr. Reve Purisima Shields accept Medicare?

Yes. CMS data shows Dr. Shields billed Medicare for 1,177 services in 2024, and Dr. Shields accepts Medicare assignment.

Does Dr. Reve Purisima Shields offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Shields as offering telehealth services.

What is Dr. Reve Purisima Shields' MIPS score?

Dr. Shields' MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Reve Purisima Shields see?

CMS counts 457 Medicare patients who saw Dr. Shields in 2024, with an average age of 73.

What services does Dr. Reve Purisima Shields bill to Medicare?

In 2024, Dr. Shields' most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, established patient (99213).

Where did Dr. Reve Purisima Shields go to medical school?

Dr. Shields graduated from State Un of NY, Stony Brook School of Dental Med in 2005.

What drugs does Dr. Reve Purisima Shields prescribe most?

In 2024 Medicare Part D data, Dr. Shields' most prescribed drugs by claims were Anastrozole, Tamoxifen Citrate and Letrozole.

Has Dr. Reve Purisima Shields received payments from drug or device companies?

CMS Open Payments shows $2,179 in general payments to Dr. Shields from 22 companies from 2017 to 2025. The largest total came from Celgene Corporation.

How long has Dr. Reve Purisima Shields been practicing?

Dr. Shields graduated from medical school in 2005, 21 years ago.

Does Dr. Reve Purisima Shields do research?

Dmand AI links 1 publication to Dr. Shields.

Who does Dr. Reve Purisima Shields publish with?

Dr. Shields' most frequent co-authors are Jorge J. Castillo, MD (1 shared paper) and Anthony Emmanuel Mega, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)